The Effect of Sleep Quality on Coronary Artery Disease and In Stent Restenosis

National Center for Cardiovascular Diseases

Status: Unknown

Conditions: Coronary Artery Disease; In-stent Restenosis

Treatments: Other: Observation

Study type: Observational

Funder types: Other

Identifiers

NCT03874481

T2018-ZX026

Details and patient eligibility

About

This is a cross-sectional and follow-up study. We analysis the relationship of sleep quality on coronary artery disease(CAD) and in stent restenosis(ISR). Further, we explore the mechanism of relationship between the sleep quality and CAD/ ISR by examining the biomarkers in the pathway of sleep-CAD/ISR.

Full description

Background: Coronary artery disease (CAD) is the leading cause of mortality in the world. The important treatment of CAD is Percutaneous coronary intervention(PCI). However, in-stent-restenosis(ISR) is the major issue in the PCI. The factors of ISR include gender, age, diabetes, lipid ,obesity and so on.Recently, studies showed that sleep duration and sleep quality have effect on all of factors and have relationship with coronary artery calcification. We like to explore the relationship between sleep quality and CAD/ISR.

Aims:This is a cross-sectional and follow-up study. We analysis the relationship of sleep quality on coronary artery disease(CAD) and in stent restenosis(ISR). Further, we explore the mechanism of relationship between the sleep quality and CAD/ ISR by examining the biomarkers in the pathway of sleep-CAD/ISR.

Methods: We include patients who were diagnosed as CAD by coronary arteriography. Sleep duration and quality were evaluated from sleep questionnaire. During the 6 months and 9-12months, we follow up the patients who got PCI and get information of Major Adverse Cardiovascular Events (MACE) from follow-up questionnaire. On 9-12 months after PCI, coronary arteriography were produced in PCI patients. Biomarkers were tested during the follow-up.

Enrollment: 958 estimated patients

Sex: All

Ages: 30 to 85 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Clinical diagnosis of Coronary artery disease
• PCI patients in the follow-up
• written informed consent

Exclusion criteria

• Heart failure; renal failure; secondary hypertension;valvular heart disease ;Cancer;

Trial design

958 participants in 1 patient group

PCI

Description:

Patients who had stent

Treatment:

Other: Observation